A 19th-Century Obscenity Law Is Being Used Again to Limit Abortion
Recent rulings on the abortion pill cite the Comstock Act, a 150-year-old law that’s still on the books
Josh Fischman is a senior editor at Scientific American who covers medicine, biology and science policy. He has written and edited about science and health for Discover, Science, Earth, and U.S. News & World Report. Follow Josh Fischman on Twitter.
Recent rulings on the abortion pill cite the Comstock Act, a 150-year-old law that’s still on the books
Very high HDL cholesterol levels almost double your risk of heart problems.
A careful new study reveals coffee is generally safe for your heart and may boost your daily step count.
Post-COVID symptoms can linger for months or years, and more and more evidence points to problems with the nervous system.
A vaccine pioneer tells us that shots to protect against RSV—a dangerous virus for babies and older people—are finally nearing approval.
Hosts Josh Fischman and Tanya Lewis explore the pandemic’s mental health toll on teens and young adults. They also delve into the effectiveness of telehealth, which has been booming since the start of the pandemic...
Vaccines saved New York City billions of dollars, and China faces public fury over its strict virus-control policies.
In a new episode of the COVID, Quickly podcast, we talk about the variants that are likely to be around this winter and how boosters help even if you’ve already had the disease...
In this episode of the COVID, Quickly podcast, we talk about why we’ve had years shaved off our average collective life since 2020. Also, we talk about “mabs” and why you might want to know what they are...
Carolyn R. Bertozzi, Morten Meldal and K. Barry Sharpless share the Nobel Prize in Chemistry for discovering an easy way to “click” molecular building blocks together
On this episode of the COVID, Quickly podcast, Josh Fischman gets COVID, and President Joe Biden says the pandemic is over.
This is our second back-to-school special episode of COVID. Quickly . Today we talk about two big issues: the low vaccination rates among the littlest kids and how long you should quarantine after being sick (actually)...
This is our back-to-school special episode of COVID, Quickly . We’ll talk about why COVID testing is about to become a school problem—and about whether or not kids are at risk for long COVID...
On this episode of the COVID, Quickly podcast, we take a few minutes to talk about the other virus making headlines—and then return to long COVID.
On this episode of the COVID, Quickly podcast, we talk about getting reinfected with the coronavirus just a month or two after an earlier bout—and the difference that trusting others can make in a pandemic...
On this episode of the COVID, Quickly podcast, we talk about the increase in new Omicron subvariants. Should fall vaccine boosters contain standard Omicron or some of those new subvariants instead?...
On this episode of the COVID, Quickly podcast, we discuss some parents breathing a collective sigh of relief and the paradox of how effective vaccines can make it harder to create new drugs to treat patients who get the coronavirus...
On this episode of the COVID, Quickly podcast, we clear up some data misconceptions, get to the bottom of the booster uptake issue and talk Novavax.
Today we bring you a new episode in our podcast series COVID, Quickly. Every two weeks, Scientific American ’s senior health editors Tanya Lewis and Josh Fischman catch you up on the essential developments in the pandemic: from vaccines to new variants and everything in between...
Today we bring you a new episode in our podcast series COVID, Quickly. Every two weeks, Scientific American ’s senior health editors Tanya Lewis and Josh Fischman catch you up on the essential developments in the pandemic: from vaccines to new variants and everything in between...
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account